Release Date: 24/09/18 09:08 Summary: Change in substantial holding from LKO Price Sensitive: No Download Document 146.96KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%